Progress report High sensitivity and low cost human PET system: viability tests POCI/SAU-OBS/61642/2004 J. J. Pedroso de Lima.

Slides:



Advertisements
Similar presentations
CT Scanning: Dosimetry and Artefacts
Advertisements

Computers and Computed Tomography
Hong CM, Ahn BC, Jeong SY, Lee SW, Lee J
Large cell carcinoma Accounts for 5-10% of all lung cancers.
PET Radiopharmaceuticals by Stephen M. Karesh, Ph.D.
tomos = slice, graphein = to write
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
JHSGR 16 th April 2011 Dr Lee Man Kit Derek.  The value of PET in staging adenocarcinoma (e.g. colorectal cancer) is well established Tomoharu T. et.
Radioisotopes in Medicine
By : Alanoud Al Saleh. What is PACS quality control ? The PACS monitor quality control (QC) program objectives are:  to ensure consistent display performance.
lecture 2, linear imaging systems Linear Imaging Systems Example: The Pinhole camera Outline  General goals, definitions  Linear Imaging Systems.
Lecture 6 Review of Units used in Radiation Safety and Radiation Biology Assessment of Public Dose Unauthorized Use/Removal of Radioactive Materials Misadministrations.
Chemistry and Imaging. Body Chemistry In order to be an effective health care professional, an individual must have an understanding of basic chemistry.
1 © 2015, Elsevier Inc., Heymann, Bone Cancer, Second Edition Chapter 45 DIAGNOSIS OF BONE METASTASES IN UROLOGICAL MALIGNANCIES - AN UPDATE.
COMPUTED TOMOGRAPHY I – RAD 365 CT - Scan
8/18/2015G.A. Fornaro Characterization of diffractive optical elements for improving the performance of an endoscopic TOF- PET detector head Student: G.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
The Role of Imaging in Sinusitis Dr Mohamed El Safwany, MD.
Introduction to Nuclear Medicine
MEDICAL IMAGING.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
Very High Resolution Small Animal PET Don J. Burdette Department of Physics.
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
Positron Emission Tomography (PET)
Procedure Guidelines and Practical Applications For PET \CT Imaging by Dr. H. Hawesa RAD 466-Lecture 7.
May 2015ECFA meeting1 Spin-off technologies for cancer diagnosis J. Varela, LIP Lisbon ECFA meeting, Coimbra, 15 May, 2015.
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
radio-iodinated metaiodobenzylguanidine (123I-MIBG)
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
IDEAL ASSIST (Automated Spine Survey Iterative Scan Technique): Metastasis Detection Introduction Multi-parametric MRI of the entire spine is technologist-
M. Alnafea1*, K. Wells1, N.M. Spyrou1 & M. Guy2
Review of Ultrasonic Imaging
Ragnar Hellborg Lund University PRODUCTION OF CLINICALLY USEFUL QUANTITIES OF 18 F BY AN ELECTROSTATIC TANDEM ACCELERATOR Ragnar Hellborg Lund University,
Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.
WELCOME. PET/CT CASE REVIEW COURSE JANUARY 31 ST PASADENA CONVENTION CENTER LOS ANGELES RADIOLOGIC SOCIETY MID WINTER MEETING.
Visceral Adiposity at Diagnosis Correlates with Tumor Size and Metastatic Progression in Clear Cell Renal Carcinoma A Shuster, MD (1), M Patlas, MD (1),
Rebecca Barrett CRYSTAL LAB. PET Detects gamma rays Interact with the crystals and release photons Smaller the crystal, the less uncertainty.
ACRIN 6682 Phase II Trial OF 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/4/08.
Improved Hybrid PET Imaging Using Variable Focal Length Fan-Slat Collimators Thomas C. Rust and Dan J. Kadrmas, Ph.D. Medical Imaging Research Laboratory.
PET/MR in Oncology: Non– 18 F- FDG Tracers for Routine Applications R2 丁建鑫.
Nuclear Medicine and PET rev this is now slide 1do not print it to pdf things to do (check off when complete): add revision date to cover page.
Nuclear Medicine Physics and Equipment 243 RAD 1 Dr. Abdo Mansour Assistant Professor of radiology
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
TISSUE HARMONIC IMAGING (THI)
Segmentation of 3D microPET Images of the Rat Brain by Hybrid GMM and KDE Tai-Been Chen Department of Medical Imaging and Radiological Science,
PET Imaging Positron Emission Tomography
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
Sonography and Ovarian Tumors Professor Galal Lotfi Obstetrics & Gynecology Suez Canal University. Egypt.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
Practical Oncology Experiences. What are the POEs? Practical sessions Promote understanding of technical aspects of Radiation Oncology Interaction with.
Tumor markers 1111.
Nuclear imaging for prostate cancer: What’s new?
Prof. Stefaan Vandenberghe Enrico Clementel
Part XII Homeland security.
Quantitative Nuclear Medicine Imaging
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Presentation of the health pole Philippe Laniece (IMNC)
Detailed simulations of a full-body RPC-PET scanner
CNRS applications in medical imaging
Two lesions are seen within the lateral segment of the left lobe of the liver (yellow arrows). They appear mildly hyperintense on T2 images and mildly.
Applications of Diagnostic Imaging Nuclear Medicine
Review of Ultrasonic Imaging
Adrian G. Sacher, MD, Kimberly M. Komatsubara, MD, Geoffrey R
Radioisotopes in Medicine
Volume 65, Issue 4, Pages (April 2014)
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Ultrasound Despeckling for Contrast Enhancement
Metabolic PHENOTYPE by NMR spectroscopy: A biomarker for lung CANCER
Presentation transcript:

Progress report High sensitivity and low cost human PET system: viability tests POCI/SAU-OBS/61642/2004 J. J. Pedroso de Lima

PET is a valuable clinical tool, namely for detecting cancer, evaluating heart function and assessing neurological conditions. PET is the most sensitive and specific technique to visualise, in vivo, the paths and interactions of molecules in human tissues and organs. PET diagnosis is based upon metabolic changes in tissues or cells.

By imaging 18 F-FDG ( 18 F-fluoro- deoxyglucose) uptake, functional information is obtained on where tissues are located and how active and fast-growing they are. Whole Body PET (WBP) scans are performed mainly to survey the body for sites of metastatic cancer cells and to make accurate tumor staging encompassing the entire body.

Whole body PET of a pacient with metastatic disease - 18 F-FDG Whole body PET - allows images of metastatic disease spread and other oncological situations in whole body projections (anterior, posterior and lateral). The information is qualitative.

Although being widely recognized, WBP is time consuming (takes about 30 to 40 min with existing systems), not adapted to a systematic screening, it is often limited by the high level of statistical noise in the images and it is felt that a better definition in the images would be a valuable step forward.

In the project being reported, the sensitivity characteristics of a resistive plate chamber (RPC)–PET system with wide Axial Field of View (AFOV) for human PET technology was studied through Monte Carlo simulations, complemented by an approximate analytical model, aiming at whole-body human PET systems with AFOV in the order of 200 cm.

It was proved that the sensitivity, dominated by the solid angle, grows strongly with the AFOV and with the axial acceptance angle, while the scatter fraction is almost independent from the geometry.

Simulations suggest that the sensitivity of such systems for human whole-body screening, under reasonable assumptions, may exceed the present crystal-based PET technology by a factor up to 20. The spatial resolution of the new device is better than the existing systems and its cost much lower.

Additionally the cost-effectiveness of these detectors and their very good timing characteristics opens the possibility to build affordable Time of Flight (TOF)–PET systems with very large fields of view.

These characteristics show that this project is in the right direction in what concerns the development of a new concept on WBP studies, i.e., a device based upon RPCs that is faster, allowing higher patient throughput, with better spatial resolution and much cheaper than the conventional systems. As work for the future the integration of RPC-PET in a PET-CT system is an other important goal.